Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma

Fig. 4

Pre-treatment with decitabine enhances susceptibility to carboplatin cytotoxicity. Apoptotic melanoma cells after treatment with 0.26 μM decitabine, 8 μg/mL carboplatin or both in sequential combination was quantified in melanoma cell lines by flow cytometry. Baseline with no treatment was used as a control. Data represents mean of triplicates of three individual experiments, bars = SEM. **p < 0.01

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us